U.S. Markets open in 9 hrs 30 mins

Corvus: 2Q Earnings Snapshot

BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported a loss of $13 million in its second quarter.

The Burlingame, California-based company said it had a loss of 44 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

In the final minutes of trading on Thursday, the company's shares hit $3.83. A year ago, they were trading at $9.72.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS